Health Matters Podcast, New York-Presbyterian Hospital, November 2024
However, there is a lack of large, randomized clinical trials in humans, so the current level of evidence should be considered preliminary
Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells
You will also be able to review and discuss any images or previous lab work and test results that you uploaded before your visit
La respuesta glucmica inadecuada tras 3-6 meses sugiere necesidad de intensificacin, ya sea aumentando dosis, cambiando de agente o aadiendo terapia complementaria
The medications and therapeutic strategies discussed may not be suitable for everyone and can have significant risks and side effects